← Back to Search

Microfluidics Device

ZyMot Multi Sperm Separation Device (850 ul) for Assisted Reproductive Technology

Waitlist Available
Led By Rani Fritz, DO, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up culture day 5 or 6
Awards & highlights


This trial will compare the success of two different methods of separating sperm for ICSI.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~culture day 5 or 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and culture day 5 or 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Good Quality Blastocyst Formation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ZyMot SeparationExperimental Treatment1 Intervention
Group II: Density Gradient CentrifugationActive Control1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
ZyMot Multi Sperm Separation Device (850 ul)

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,379 Previous Clinical Trials
848,010 Total Patients Enrolled
Rani Fritz, DO, PhDPrincipal InvestigatorNYU Langone Health
~26 spots leftby Jul 2025